| Commodity | Region/Indoora | Residue levels observed in the supervised residue trials (mg/kg) | Comments/Source | Calculated MRL (mg/kg) | HRb (mg/kg) | STMRc (mg/kg) | CFd |
|---|---|---|---|---|---|---|---|
| Peanuts | USA | Mo: 12 × < 0.01; 0.016 RA: 2 × < 0.031; 0.032; 0.033; 0.034; 0.045; 2 × 0.047; 0.061; 0.062; 0.065; 2 × 0.099 | Residue trials on peanuts compliant with GAP. MRLOECD = 0.017 | 0.02 | Mo: 0.016 RA: 0.099 | Mo: < 0.01 RA: 0.047 | 6e |
a
NEU: Outdoor trials conducted in northern Europe, SEU: Outdoor trials conducted in southern Europe, Indoor: indoor EU trials or Country code: if non‐EU trials.
b
Highest residue. The highest residue for risk assessment refers to the whole commodity and not to the edible portion.
c
Supervised trials median residue. The median residue for risk assessment refers to the whole commodity and not to the edible portion.
d
Conversion factor to recalculate residues according to the residue definition for monitoring to the residue definition for risk assessment.
e
The CF is indicative as it is derived on the basis of the unique trial where a result above the LOQ was found for flutolanil (0.099/0.016).